首页> 外文期刊>International Journal of Animal and Veterinary Advances >Evaluation of Serumal Levels of AST, ALT, Total Bilirubin, Glucose, Urea and Creatinin in Mice after Administration of Tc-99m MIBI
【24h】

Evaluation of Serumal Levels of AST, ALT, Total Bilirubin, Glucose, Urea and Creatinin in Mice after Administration of Tc-99m MIBI

机译:Tc-99m MIBI给药后小鼠血清AST,ALT,总胆红素,葡萄糖,尿素和肌酐水平的评估

获取原文
       

摘要

Tc-99m MIBI methoxyisobutylisonitrile (MIBI) is a lipophilic cationic agent which is widely used for myocardial perfusion imaging and also for the detection of various tumors. In present study, for evaluation of serum level of AST, ALT, Total bilirubin, FBC, Urea and Creatinin, 25 mice, respectively were selected and they were divided in 5 groups. 0.3 mC/kg of drug was injected to 4 groups via tail vein. In the control group, before beginning of the investigation bleeding was done. Twenty four hours after injection from the 2nd group, 48 h later from the 3rd group, one week later from the 4th group and two weeks later from the 5th group bleeding was done respectively and the levels of Glucose, Urea, creatinin, ALT, AST and T-bilirubin, respectively were measured using spectophotometr (Biowave S2100 made in England) and diagnostic kits (made in bio-chemistry company, Iran). In Comparison to control group, results had significant differences in serum level of Urea, Creatinin and total bilirubin after 24 and 48 h of administration(p<0.05). Also there were insignificant differences in serum ALT and AST level and Glucose after 24 h of administration in all groups (p<0.05). Results shows that more care is needed for administration of drug in diabetic, renal and hepatic patients.
机译:Tc-99m MIBI甲氧基异丁烯腈(MIBI)是一种亲脂性阳离子试剂,已广泛用于心肌灌注成像以及各种肿瘤的检测。在本研究中,为评估血清AST,ALT,总胆红素,FBC,尿素和肌酐水平,分别选择了25只小鼠,分为5组。通过尾静脉将0.3 mC / kg的药物注射到4组中。在对照组中,在开始研究之前已经完成了出血。第二组注射后二十四小时,第三组注射后48小时,第四组注射后一周,第五组注射后两周,血糖,尿素,肌酐,ALT,AST水平使用spectophotometr(英国的Biowave S2100)和诊断试剂盒(伊朗的生物化学公司制造)分别测量T-胆红素和T-胆红素。与对照组比较,给药24和48小时后,尿素,肌酐和总胆红素水平有显着差异(p <0.05)。所有组在给药24小时后血清ALT,AST和葡萄糖水平也无显着差异(p <0.05)。结果表明,在糖尿病,肾和肝病患者中需要更多的药物管理。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号